Reviewing XORTX Therapeutics (NASDAQ:XRTX) & Sandoz Group (OTCMKTS:SDZNY)

XORTX Therapeutics (NASDAQ:XRTX) and Sandoz Group (OTCMKTS:SDZNY) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and price targets for XORTX Therapeutics and Sandoz Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
XORTX Therapeutics	1	0	0	0	1.00
Sandoz Group	0	2	0	2	3.00

Valuation and Earnings

This table compares XORTX Therapeutics and Sandoz Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XORTX Therapeutics	N/A	N/A	-$2.66 million	($3.00)	-1.01
Sandoz Group	$11.09 billion	3.21	$914.00 million	N/A	N/A

Sandoz Group has higher revenue and earnings than XORTX Therapeutics.

Profitability

This table compares XORTX Therapeutics and Sandoz Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
XORTX Therapeutics	N/A	-120.32%	-90.53%
Sandoz Group	N/A	N/A	N/A

Volatility & Risk

XORTX Therapeutics has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Sandoz Group has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.

Insider and Institutional Ownership

0.2% of XORTX Therapeutics shares are owned by institutional investors. Comparatively, 0.1% of Sandoz Group shares are owned by institutional investors. 6.9% of XORTX Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Sandoz Group beats XORTX Therapeutics on 7 of the 9 factors compared between the two stocks.

About XORTX Therapeutics

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.